84 research outputs found

    Reynolds stresses and mean fields generated by pure waves: applications to shear flows and convection in a rotating shell

    Get PDF
    A general reformulation of the Reynolds stresses created by two-dimensional waves breaking a translational or a rotational invariance is described. This reformulation emphasizes the importance of a geometrical factor: the slope of the separatrices of the wave flow. Its physical relevance is illustrated by two model systems: waves destabilizing open shear flows; and thermal Rossby waves in spherical shell convection with rotation. In the case of shear-flow waves, a new expression of the Reynolds–Orr amplification mechanism is obtained, and a good understanding of the form of the mean pressure and velocity fields created by weakly nonlinear waves is gained. In the case of thermal Rossby waves, results of a three-dimensional code using no-slip boundary conditions are presented in the nonlinear regime, and compared with those of a two-dimensional quasi-geostrophic model. A semi-quantitative agreement is obtained on the flow amplitudes, but discrepancies are observed concerning the nonlinear frequency shifts. With the quasi-geostrophic model we also revisit a geometrical formula proposed by Zhang to interpret the form of the zonal flow created by the waves, and explore the very low Ekman-number regime. A change in the nature of the wave bifurcation, from supercritical to subcritical, is found

    Pretransplant identification of acute rejection risk following kidney transplantation

    Get PDF
    Lack of an accepted definition for 'high immunological risk' hampers individualization of immunosuppressive therapy after kidney transplantation. For recipient-related risk factors for acute rejection, the most compelling evidence points to younger age and African American ethnicity. Recipient gender, body mass, previous transplantation, and concomitant infection or disease do not appear to be influential. Deceased donation now has only a minor effect on rejection risk, but older donor age remains a significant predictor. Conventional immunological markers (human leukocyte antigen [HLA] mismatching, pretransplant anti-HLA alloantibodies, and panel reactive antibodies) are being reassessed in light of growing understanding about the role of donor-specific antibodies (DSA). At the time of transplant, delayed graft function is one of the most clear-cut risk factors for acute rejection. Extended cold ischemia time (≥24 h) may also play a contributory role. While it is not yet possible to establish conclusively the relative contribution of different risk factors for acute rejection after kidney transplantation, the available data point to variables that should be taken into account at the time of transplant. Together, these offer a realistic basis for planning an appropriate immunosuppression regimen in individual patients

    Influence of FK 506 (tacrolimus) on circulating CD4 <sup>+</sup> t cells expressing cd25 and cd45ra antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial

    Get PDF
    We have taken the opportunity of a clinical trial of the potential efficacy and safety of FK 506 (tacrolimus) in chronic progressive multiple sclerosis (MS) to examine the influence of this potent new immunosuppressant on circulating T-lymphocytes in an otherwise healthy non-transplant population. Peripheral blood levels of subsets of CD4+ T lymphocytes expressing the activation molecule interleukin-2 receptor (p55 α chain; CD25) or the CD45RA isoform were determined sequentially in 19 patients that were treated continuously with oral FK 506 (starting dose 0.15 mg/kg/day) for 12 months. No significant change in the proportion of circulating CD25 + CD4+ cells was observed over the study period in which the mean trough plasma FK 506 level rose from 0.3 ±0.2 to 0.5 ±0.4 ng/ml. There was also no significant effect of FK 506 on the percentage of CD45RA + CD4 + cells in the peripheral blood at 12 months compared with pretreatment values. Analysis of a subgroup of 7 patients, who showed a sustained reduction in CD25 + CD4+ cells and a reciprocal increase in CD45RA* CD4 * cells for at least 6 months after start of treatment, did not reveal any difference in disability at one year compared with the treatment group as a whole. The side effects of FK 506 were mild and the overall degree of disability estimated by the mean Kurtzke expanded disability status scale (EDSS) score or the ambulation index did not deteriorate significantly in the 19 patients studied over the 12 months of FK 506 administration. © 1994 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted

    Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies

    Get PDF
    Abstract View references (47) The presence of preformed donor-specific antibodies in transplant recipients increases the risk of acute antibody-mediated rejection (AMR). Results of an open-label single-arm trial to evaluate the safety and efficacy of eculizumab in preventing acute AMR in recipients of deceased-donor kidney transplants with preformed donor-specific antibodies are reported. Participants received eculizumab as follows: 1200 mg immediately before reperfusion; 900 mg on posttransplant days 1, 7, 14, 21, and 28; and 1200 mg at weeks 5, 7, and 9. All patients received thymoglobulin induction therapy and standard maintenance immunosuppression including steroids. The primary end point was treatment failure rate, a composite of biopsy-proved grade II/III AMR (Banff 2007 criteria), graft loss, death, or loss to follow-up, within 9 weeks posttransplant. Eighty patients received transplants (48 women); the median age was 52 years (range 24-70 years). Observed treatment failure rate (8.8%) was significantly lower than expected for standard care (40%; P <.001). By 9 weeks, 3 of 80 patients had experienced AMR, and 4 of 80 had experienced graft loss. At 36 months, graft and patient survival rates were 83.4% and 91.5%, respectively. Eculizumab was well tolerated and no new safety concerns were identified. Eculizumab has the potential to provide prophylaxis against injury caused by acute AMR in such patients (EudraCT 2010-019631-35). \ua9 2019 The Authors. American Journal of Transplantation published by Wiley Periodicals, Inc. on behalf of The American Society of Transplantation and the American Society of Transplant Surgeon

    A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.

    Get PDF
    PURPOSE: Patients with primary immunodeficiency (PID) are at risk of serious complications. However, data on the incidence and causes of emergency hospital admissions are scarce. The primary objective of the present study was to describe emergency hospital admissions among patients with PID, with a view to identifying "at-risk" patient profiles. METHODS: We performed a prospective observational 12-month multicenter study in France via the CEREDIH network of regional PID reference centers from November 2010 to October 2011. All patients with PIDs requiring emergency hospital admission were included. RESULTS: A total of 200 admissions concerned 137 patients (73 adults and 64 children, 53% of whom had antibody deficiencies). Thirty admissions were reported for 16 hematopoietic stem cell transplantation recipients. When considering the 170 admissions of non-transplant patients, 149 (85%) were related to acute infections (respiratory tract infections and gastrointestinal tract infections in 72 (36%) and 34 (17%) of cases, respectively). Seventy-seven percent of the admissions occurred during winter or spring (December to May). The in-hospital mortality rate was 8.8% (12 patients); death was related to a severe infection in 11 cases (8%) and Epstein-Barr virus-induced lymphoma in 1 case. Patients with a central venous catheter (n = 19, 13.9%) were significantly more hospitalized for an infection (94.7%) than for a non-infectious reason (5.3%) (p = 0.04). CONCLUSION: Our data showed that the annual incidence of emergency hospital admission among patients with PID is 3.4%. The leading cause of emergency hospital admission was an acute infection, and having a central venous catheter was associated with a significantly greater risk of admission for an infectious episode

    Structure and stability of annular sheared channel flows: effects of confinement, curvature and inertial forces – waves

    No full text
    The structure and stability of the flows in an annular channel sheared by a rotating lid are investigated experimentally, theoretically and numerically. The channel has a square section, and a small curvature parameter: the ratio Γ of the inter-radii to the mean radius is 9.5%. The sidewalls and the bottom of the channel are integral and can rotate independently of the lid, permitting pure shear, co-rotation and counter-rotation cases. The basic flows obtained at small shear are characterized. In the absence of co-rotation, the centrifugal force linked with the curvature of the system plays an important role, whereas, when co-rotation is fast, the Coriolis force dominates. These basic flows undergo some instabilities when the shear is increased. These instabilities lead to supercritical traveling waves in the pure shear and co-rotation cases, but to weak turbulence in the counter-rotation case. The Reynolds number for the onset of instabilities, constructed with the velocity difference between the lid and bottom at mid-radius, and the height of the channel, increases from 1000 in the counter-rotation case to 1260 in the pure shear case and higher and higher values when co-rotation increases, i.e., when the Coriolis effect increases. The relevance of uni-dimensional Ginzburg-Landau models to describe the dynamics of the waves is studied. The domain of validity of these models turns out to be quite narrow. Copyright EDP Sciences, SIF, Springer-Verlag Berlin Heidelberg 2011
    corecore